A New Multimodal Molecular Imaging Approach to Guide Intra-Operative Tumor Resection and Post-Operative Treatment Planning

一种新的多模态分子成像方法来指导术中肿瘤切除和术后治疗计划

基本信息

  • 批准号:
    10578468
  • 负责人:
  • 金额:
    $ 62.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary The first line of treatment for several cancer patients is surgical debulking which can suffer from poor tumor localization resulting in lengthy incomplete surgeries and repeat visits. Our objective is to provide physicians with an entirely new multimodal molecular imaging strategy that has the potential to offer 1) intra-operative surgical guidance to ensure complete resection of the tumor, and 2) post-operative molecular expression information to improve therapeutic decision-making. Oral squamous cell carcinoma (OSCC) is an ideal cancer on which to develop our new multimodal imaging approach as it suffers from poor tumor demarcation and is easy to access with optical imaging tools. We intend to develop an entirely new class of multimodal nanoparticles (NPs) to serve as our tumor targeting contrast agents. These new NPs are intended to provide real-time fluorescence image guidance during tumor resection and Raman multiplexed imaging to identify molecular expression and drug target availability for effective therapy. These multimodal NPs have the potential to provide physicians with a molecular map of the tumor with improved sensitivity and specificity not previously achievable with existing single mode molecular imaging technologies. Ongoing attempts toward developing new contrast agents have faced major problems in gaining regulatory approval. Our innovative approach utilizes the dyes that are already FDA approved for the coloring of our foods, drugs and cosmetics. Color is all around us, however, we often take for granted the sources of the vibrant colors we enjoy in our favorite candy, cosmetics and clothing. After curiously considering that these “colorful” organic dyes could offer more than just aesthetics, we recently discovered that they in fact have a multitude of useful optical properties (e.g. absorbance, fluorescence, Raman scattering) that make them ideal for imaging applications. We propose to integrate these dyes and their multimodal imaging capabilities into a nanoparticle construct specially designed to provide useful imaging contrast that enables improved cancer detection, localization and molecular profiling. We will begin our study by characterizing the physical characteristics of these newly fabricated NPs and their multimodal imaging capabilities. This will include in-vivo evaluation of their biodistribution and extravasation properties by utilizing multiple molecular imaging tools. We will then test their tumor targeting efficiency in cell culture and on human tissue. Our nanoparticles will actively target tumors through chemically conjugated targeting ligands and/or passively target the tumor through the enhanced permeability and retention effect. We will assess the tumor targeting efficiency and surgical navigation potential of our newly developed NPs with pre-existing preclinical and clinical molecular imaging tools. These studies will enable the repurposing of these aesthetically pleasing household organic dyes as multimodal imaging probes to enable an entirely new, and clinically translatable, paradigm. The images generated from these multimodal nanoparticles could improve cancer detection and localization for improved surgical resection, but also aid clinicians in the design of treatment protocols which are most suitable for the individual patient.
项目摘要 一线治疗的几个癌症患者是手术减瘤,可遭受穷人的肿瘤 本地化导致冗长的不完整手术和重复访问。我们的目标是为医生提供 一种全新的多模式分子成像策略,有可能提供1)术中手术 指导以确保肿瘤的完全切除,和2)术后分子表达信息, 改善治疗决策。口腔鳞状细胞癌(OSCC)是一种理想的癌症, 开发我们新的多模式成像方法,因为它的肿瘤分界差,易于访问 光学成像工具。我们打算开发一种全新的多峰纳米颗粒(NPs), 作为我们的肿瘤靶向造影剂这些新纳米粒子旨在提供实时荧光图像 肿瘤切除和拉曼多重成像过程中的指导,以识别分子表达和药物 有效治疗的目标可用性。这些多模态纳米颗粒有可能为医生提供一个 肿瘤的分子图谱,具有以前用现有的单一方法无法实现的提高的灵敏度和特异性 模式分子成像技术。正在进行的开发新造影剂的尝试面临着 获得监管部门批准的主要问题。我们的创新方法利用了FDA已经批准的染料, 用于食品药品和化妆品的着色色彩就在我们身边,然而,我们常常把它当作 我们喜爱的糖果、化妆品和服装中的鲜艳色彩来源于此。在好奇地 考虑到这些“彩色”有机染料可以提供的不仅仅是美学,我们最近发现, 它们实际上具有多种有用的光学性质(例如,吸光度、荧光、拉曼散射), 使其成为成像应用的理想选择。我们建议整合这些染料和他们的多模态成像 纳米粒子结构专门设计用于提供有用的成像对比度, 改进癌症检测、定位和分子分析。我们将开始我们的研究, 这些新制造的NP的物理特性及其多模态成像能力。这将包括 通过利用多分子成像对其生物分布和外渗性质的体内评价 工具.然后,我们将在细胞培养和人体组织中测试它们的肿瘤靶向效率。我们的纳米粒子 通过化学缀合的靶向配体主动靶向肿瘤和/或通过化学缀合的靶向配体被动靶向肿瘤, 增强的渗透性和保留效果。我们将评估肿瘤靶向效率和外科手术 我们新开发的纳米粒子与现有的临床前和临床分子成像工具的导航潜力。 这些研究将使这些美观的家用有机染料的再利用成为多模态 成像探针,以实现一个全新的,临床上可翻译的范例。生成的图像 这些多模态纳米颗粒可以改善癌症检测和定位以改善手术切除, 而且还帮助临床医生设计最适合于个体患者的治疗方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cristina L. Zavaleta其他文献

Cristina L. Zavaleta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cristina L. Zavaleta', 18)}}的其他基金

Supplement to Support the Development of a New Multiplexed Imaging Tool using Raman Spectroscopy for Breast Cancer
支持开发使用拉曼光谱治疗乳腺癌的新型多重成像工具的补充材料
  • 批准号:
    10839117
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
A New Strategy for Cancer Detection using Raman Spectroscopy with Nanoparticles
使用纳米颗粒拉曼光谱检测癌症的新策略
  • 批准号:
    8700750
  • 财政年份:
    2014
  • 资助金额:
    $ 62.76万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 62.76万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了